Novartis AG
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Revenue Share of Largest Pharmaceutical Distributor by Year
Revenue Share of Largest Pharmaceutical Distributor — Customer #1 (McKesson / Cencora / Cardinal Health) (%)
Novartis Revenue Share of Largest Pharmaceutical Distributor: 18.0% in FY2025, up 1.0 pts from a year earlier.
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
The 3 largest US pharmaceutical wholesalers accounted for a combined ~38% of Novartis' consolidated global revenue in FY2025.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Revenue Share of Largest Pharmaceutical Distributor — Customer #1 (McKesson / Cencora / Cardinal Health) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.0% | +1.0 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 17.0% | +2.0 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 15.0% | -1.0 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2022 | Dec 31, 2022 | 16.0% | +2.0 pts | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2021 | Dec 31, 2021 | 14.0% | -3.0 pts | Novartis Form 20-F (0001370368-24-000004) ↗ |
| FY2020 | Dec 31, 2020 | 17.0% | -1.0 pts | Novartis Form 20-F/A (0001370368-23-000048) ↗ |
| FY2019 | Dec 31, 2019 | 18.0% | 0.0 pts | Novartis Form 20-F (0001370368-22-000010) ↗ |
| FY2018 | Dec 31, 2018 | 18.0% | -1.0 pts | Novartis Form 20-F (0001370368-21-000006) ↗ |
| FY2017 | Dec 31, 2017 | 19.0% | +3.0 pts | Novartis Form 20-F (0001370368-20-000003) ↗ |
| FY2016 | Dec 31, 2016 | 16.0% | – | Novartis Form 20-F (0001370368-19-000002) ↗ |
Breakdown
What makes up revenue Share of Largest Pharmaceutical Distributor
- Revenue Share of 2nd Largest Distributor — Customer #2 (%)13.0% · FY2025
- Revenue Share of 3rd Largest Distributor — Customer #3 (%)7.0% · FY2025
- Trade Receivables Share of Largest Distributor — Customer #1 (%)16.0% · FY2025
- Trade Receivables Share of 2nd Largest Distributor — Customer #2 (%)12.0% · FY2025
- Trade Receivables Share of 3rd Largest Distributor — Customer #3 (%)6.0% · FY2025
Cite this data
StockData. (2026). Novartis Revenue Share of Largest Pharmaceutical Distributor (%), annual FY2016–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/cust-conc-rev-top1-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.